SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041705
Filing Date
2019-11-07
Accepted
2019-11-07 16:01:50
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20190930.htm 10-Q 2091750
2 EX-31.1 sbph-ex311_6.htm EX-31.1 23508
3 EX-31.2 sbph-ex312_7.htm EX-31.2 23085
4 EX-32.1 sbph-ex321_8.htm EX-32.1 16118
  Complete submission text file 0001564590-19-041705.txt   8636766

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20190930.xml EX-101.INS 2058131
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20190930.xsd EX-101.SCH 58009
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20190930_cal.xml EX-101.CAL 61209
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20190930_def.xml EX-101.DEF 205883
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20190930_lab.xml EX-101.LAB 481571
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20190930_pre.xml EX-101.PRE 384443
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 191200187
SIC: 2834 Pharmaceutical Preparations